A Phase IV, Randomized, Observer-Blind, Multi-Center, Non Inferiority Comparison of the Immune Response of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Inactivated Split-Virion Influenza Vaccine in Adults Aged Greater Than or Equal to 65 Years.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Influenza virus vaccine (Afluria) (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors CSL; Seqirus
- 11 Sep 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 11 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 02 Oct 2008 Actual start date (Oct 2009) added as reported by Clinicaltrials.gov.